Analyst Ratings For Immutep (NASDAQ:IMMP) (NASDAQ:IMMP)
Today, Maxim Group reiterated its Buy rating on Immutep (NASDAQ:IMMP) (NASDAQ:IMMP) with a price target of $5.00.
Some recent analyst ratings include
- 3/22/2018-Maxim Group Reiterated Rating of Buy.
- 4/19/2017-FBR & Co Reiterated Rating of Buy.
- 8/26/2016-Roth Capital Reiterated Rating of Buy.
Recent Trading Activity for Immutep (NASDAQ:IMMP) (NASDAQ:IMMP)
Shares of Immutep (NASDAQ:IMMP) closed the previous trading session at 1.91 up +0.02 1.25% with 1.9199999570846558 shares trading hands.